(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.46%) $81.55
(-1.71%) $1.957
(-0.24%) $2 297.30
(-0.32%) $26.57
(-0.25%) $945.80
(0.53%) $0.937
(1.33%) $11.13
(0.56%) $0.800
(0.16%) $93.45
Live Chart Being Loaded With Signals
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer...
Stats | |
---|---|
Dagens volum | 12.99M |
Gjennomsnittsvolum | 0 |
Markedsverdi | 0.00 |
Last Dividend | ¥0.800 ( 2012-12-26 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | -0.0564 |
ATR14 | ¥0 (0.00%) |
tella, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
tella, Inc. Økonomi
Annual | 2021 |
Omsetning: | ¥106.41M |
Bruttogevinst: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2021 |
Omsetning: | ¥106.41M |
Bruttogevinst: | ¥-98.59M (-92.65 %) |
EPS: | ¥-9.04 |
FY | 2020 |
Omsetning: | ¥76.36M |
Bruttogevinst: | ¥-37.44M (-49.02 %) |
EPS: | ¥-45.26 |
FY | 2019 |
Omsetning: | ¥202.18M |
Bruttogevinst: | ¥44.81M (22.16 %) |
EPS: | ¥-53.81 |
Financial Reports:
No articles found.
tella, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
First Dividend | ¥0.600 | 2010-12-28 |
Last Dividend | ¥0.800 | 2012-12-26 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | ¥1.400 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.22 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6879.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6250.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
4970.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4182.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3361.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
2438.T | Ex Dividend Junior | 2024-04-26 | Annually | 0 | 0.00% | |
9948.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
8957.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
8060.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
7326.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -8.92 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -2.91 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.442 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.18 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.043 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 1.043 | 1.500 | 5.31 | 7.97 | [0.2 - 2] |
debtRatioTTM | 0.00805 | -1.500 | 9.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6 403.73 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -3.79 | -7.57 | [0 - 20] |
debtEquityRatioTTM | 0.0132 | -1.500 | 9.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | -0.927 | 1.000 | -10.00 | -10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -7.46 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -309.84 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.326 | 0.800 | -1.160 | -0.928 | [0.5 - 2] |
Total Score | -4.17 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.227 | 1.000 | -0.124 | 0 | [1 - 100] |
returnOnEquityTTM | -1.442 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -7.57 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -7.57 | 2.00 | -2.52 | -5.05 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.00699 | 1.500 | -3.29 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.65 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.51 |
tella, Inc.
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. It is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, the company provides consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. tella, Inc. was founded in 2004 and is based in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.